Assistant Professor, Medcial University Sofia, Bulgaria🩺
Dr. Rumen Filev is a dedicated nephrologist and academic professional based in Sofia, Bulgaria. With a strong passion for patient care and medical research, he has been actively contributing to nephrology through clinical practice, teaching, and scientific advancements. Currently serving as a Nephrologist at UMHAT “Saint Anna” AD and an Assistant Professor at the Medical University of Sofia, he is committed to mentoring future doctors while advancing nephrology research. His expertise extends to emergency medicine, hypertension, and chronic kidney disease management. Beyond his professional life, he is a devoted family man, balancing his career with personal commitments.
Profile
Google Scholar
Education 🎓
Dr. Rumen Filev holds a Medical Doctor (MD) degree from the Medical University of Sofia (2019). He further specialized in nephrology, earning a PhD from the same institution (2021–Present). Expanding his expertise in healthcare management, he completed a Master’s degree at the University of Veliko Tarnovo “St. St. Kiril and Metodi” (2020–2021). His rigorous academic training has laid a solid foundation for his contributions to nephrology, emergency medicine, and internal diseases.
Professional Experience 🏥
Dr. Filev has extensive clinical experience in nephrology and emergency medicine. He has been a Nephrologist at UMHAT “Saint Anna” AD since 2025 and an Assistant Professor at the Medical University of Sofia since 2020. His past roles include specialized doctor positions at UMHAT “Saint Anna” AD (2022–2025) and UMHAT “Aleksandrovska” EAD (2020–2022). Additionally, he has served as an emergency room doctor and volunteered in COVID-19 wards, demonstrating his commitment to critical patient care.
Research Interests 🔬
Dr. Filev’s research focuses on nephrology, hypertension, and acute kidney injury. He investigates biomarkers for predicting mortality in COVID-19 patients with kidney disease and explores innovative approaches to chronic kidney disease (CKD) management. His work also examines the impact of serum amyloid A as a prognostic marker for CKD and non-CKD patients. Actively involved in international collaborations, he contributes to advancing renal medicine through evidence-based research.
Awards & Recognitions 🏆
Dr. Filev has received multiple accolades for his scientific contributions. He was honored as one of the “Young Generation (The Doctors We Believe In)” by National Newspaper 24 Hours (2023). He also received a prestigious scholarship from Sante Espoir, France, supporting his nephrology research. Additionally, he actively participates in major nephrology forums, such as the Meeting of Young Hypertonologists and Nephrologists (VIII. MATHINÉ) and the Bulgarian Brain Stroke Society Congress.
Publications 📑
1️⃣ “Advanced Biomarkers to Predict Mortality and the Occurrence of AKI in Patients with COVID-19”
📅 April 2024 | Kidney International Reports, 9(4)
🔗 DOI: 10.1016/j.ekir.2024.02.413
2️⃣ “Serum Amyloid A as Prognostic Marker for CKD and Non-CKD COVID-19 Patients Admitted to the Emergency Room”
📅 June 2023 | Nephrology Dialysis Transplantation, 38 (Supplement-1)
🔗 DOI: 10.1093/ndt/gfad063d_3750
3️⃣ “Acute Kidney Injury Over Existing Chronic Kidney Disease in Patients with SARS-CoV-2 Infection”
📅 March 2023 | Kidney International Reports, 8(3):S430
🔗 DOI: 10.1016/j.ekir.2023.02.968
Conclusion
Rumen Filev is a strong candidate for the Best Researcher Award due to his significant contributions to nephrology, particularly in advanced biomarkers for kidney diseases. His research is innovative, well-published, and internationally recognized. While further expanding his publication record and research funding would boost his standing, his dedication to advancing nephrology through research and education makes him a deserving nominee for the award.